Business context and reporting period
This Form 10-Q was filed by Parametric Sound Corporation, the predecessor registrant to today’s Turtle Beach Corp. It covers the three months ended December 31, 2013, before Parametric’s January 15, 2014 merger with VTB Holdings, Inc. (Turtle Beach). The reported financial statements include only Parametric and its subsidiaries, not Turtle Beach; they are not representative of the combined company’s post-merger results.
The merger was accounted for as a reverse acquisition, with Turtle Beach deemed the accounting acquirer. Former Turtle Beach holders received 30,227,100 shares and represented approximately 80% of the combined company on a fully diluted basis at closing. The fiscal year-end changed to December 31.
Financial highlights
| Metric | Three months ended Dec. 31, 2013 | Prior-year comparable period |
|---|---|---|
| Revenue | $67,863 | $108,674 |
| Gross profit and margin | $31,845; 47% | $54,618; 50% |
| Operating loss | ($2,752,434) | ($1,253,832) |
| Net loss | ($2,754,310); $0.39 per share | ($1,252,120); $0.20 per share |
| Cash used in operations | ($2,032,636) | ($856,136) |
At December 31, 2013, cash was $4.67 million, current assets were $5.68 million, and current liabilities were $1.25 million. Total liabilities were $1.33 million, including $122,890 in capital lease obligations. Stockholders’ equity was $6.02 million. The quarter’s financing cash flow was $5.16 million, including $5.08 million net proceeds from a common-stock sale. Cash increased by $3.07 million during the quarter.
Operating expenses included $996,678 of merger and related litigation costs and $529,219 of share-based compensation. The filing reports no licensing revenue to date.
Material changes versus the prior period
- Revenue declined about 38%; gross margin fell from 50% to 47%, while net loss more than doubled.
- Operating cash use rose by $1.18 million. Management attributed the change primarily to the higher net loss, including merger expenses, as well as working-capital movements.
- Selling, general and administrative expense excluding share-based compensation increased to $838,257 from $725,369; research and development expense excluding share-based compensation increased to $420,125 from $329,418.
- The merger materially changed the company’s scale, ownership, management, and reporting basis. The filing’s pre-merger results should not be compared directly with future combined-company results.
Outlook, risks and unusual items
- Management expected increased HSS product sales during calendar 2014, citing expanded distribution and sales personnel, but said future sales and licensing revenue were uncertain. It expected losses to continue until revenue generated sufficient margins to cover operating costs.
- Parametric filed an FDA premarket notification seeking clearance for an HSS hearing-related product; the timing and likelihood of clearance were uncertain. A $250,000 consultant bonus would be payable if clearance occurred.
- Management believed combined-company cash, credit availability, and operating cash flows would be sufficient for anticipated needs over at least the next 12 months. This was a forward-looking assessment, not a guarantee.
- Following the merger, the company joined a credit facility under which amounts guaranteed at January 15, 2014 were $7.5 million under a term loan and approximately $39.7 million under a revolving line. The filing text does not clearly establish that these amounts were fully drawn.
- Risks included reliance on a sole supplier for HSS piezo-film, customer concentration (two customers represented 22% and 12% of quarterly revenue), and cash concentration (approximately $4.4 million exceeded FDIC insurance limits).
- Shareholder litigation sought rescission or damages; the company could not predict the outcome or estimate a possible loss range, and no amount was accrued for the claims. The filing warned that an adverse outcome could materially affect operations or finances.
- Merger-related costs expected after closing included a $1.675 million investment-banking fee, $453,000 in executive bonuses, a $250,000 consultant payment, and $350,000 of salary-continuation severance, in addition to option-acceleration costs. These were to be expensed in the first calendar quarter of 2014.
- Management stated that disclosure controls were effective at a reasonable-assurance level and reported no material changes in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Review subsequent combined-company filings for Turtle Beach’s audited results, merger purchase-price allocation, goodwill and acquired intangibles, and actual post-merger performance.
- Confirm actual debt drawn, availability and terms under the PNC credit facility, and resulting interest and covenant obligations.
- Track merger integration costs, litigation developments, and any recorded liabilities or insurance recoveries.
- Monitor HSS sales, channel expansion, gross margins, supplier alternatives, and FDA review status.
- Assess post-merger liquidity and cash burn against management’s stated 12-month liquidity expectation.